See every side of every news story
Published loading...Updated

iOncologi, Inc. Announces the Appointment of Dr. Mona Flores and Mr. Paolo Fundarò to Its Board of Directors

Summary by The AI Journal
GAINESVILLE, Fla., March 17, 2025 /PRNewswire/ — iOncologi, Inc. (www.ioncologi.com), a clinical-stage biopharmaceutical company pioneering novel immunotherapies for cancer treatment, today announced the appointment of Dr. Mona Flores and Mr. Paolo Fundarò to its Board of Directors. Their combined expertise in AI-driven healthcare innovation, biopharmaceutical leadership, and strategic biotech investment will strengthen iOncologi’s mission to ra…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The AI Journal broke the news in on Monday, March 17, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.